Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Mar;63(3):221–225. doi: 10.1136/ard.2003.012575

Patients with rheumatoid arthritis in clinical care

J Smolen, D Aletaha
PMCID: PMC1754912  PMID: 14962951

Full Text

The Full Text of this article is available as a PDF (219.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aletaha D., Eberl G., Nell V. P. K., Machold K. P., Smolen J. S. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years. Ann Rheum Dis. 2002 Jul;61(7):630–634. doi: 10.1136/ard.61.7.630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aletaha Daniel, Smolen Josef S. Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study. J Rheumatol. 2002 Aug;29(8):1631–1638. [PubMed] [Google Scholar]
  3. Aletaha Daniel, Smolen Josef S. Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysis. Arthritis Rheum. 2002 Apr 15;47(2):181–188. doi: 10.1002/art.10266. [DOI] [PubMed] [Google Scholar]
  4. Bathon J. M., Martin R. W., Fleischmann R. M., Tesser J. R., Schiff M. H., Keystone E. C., Genovese M. C., Wasko M. C., Moreland L. W., Weaver A. L. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000 Nov 30;343(22):1586–1593. doi: 10.1056/NEJM200011303432201. [DOI] [PubMed] [Google Scholar]
  5. Beaton D. E., Bombardier C., Katz J. N., Wright J. G., Wells G., Boers M., Strand V., Shea B. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol. 2001 Feb;28(2):400–405. [PubMed] [Google Scholar]
  6. Beaton D. E., Tarasuk V., Katz J. N., Wright J. G., Bombardier C. "Are you better?" A qualitative study of the meaning of recovery. Arthritis Rheum. 2001 Jun;45(3):270–279. doi: 10.1002/1529-0131(200106)45:3<270::AID-ART260>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  7. Beaton Dorcas E., Boers Marteen, Wells George A. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol. 2002 Mar;14(2):109–114. doi: 10.1097/00002281-200203000-00006. [DOI] [PubMed] [Google Scholar]
  8. Boers M., Tugwell P., Felson D. T., van Riel P. L., Kirwan J. R., Edmonds J. P., Smolen J. S., Khaltaev N., Muirden K. D. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl. 1994 Sep;41:86–89. [PubMed] [Google Scholar]
  9. Boers M., Verhoeven A. C., Markusse H. M., van de Laar M. A., Westhovens R., van Denderen J. C., van Zeben D., Dijkmans B. A., Peeters A. J., Jacobs P. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet. 1997 Aug 2;350(9074):309–318. doi: 10.1016/S0140-6736(97)01300-7. [DOI] [PubMed] [Google Scholar]
  10. Brennan P., Harrison B., Barrett E., Chakravarty K., Scott D., Silman A., Symmons D. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ. 1996 Aug 24;313(7055):471–476. doi: 10.1136/bmj.313.7055.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bresnihan B., Alvaro-Gracia J. M., Cobby M., Doherty M., Domljan Z., Emery P., Nuki G., Pavelka K., Rau R., Rozman B. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998 Dec;41(12):2196–2204. doi: 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  12. Bukhari M., Harrison B., Lunt M., Scott D. G., Symmons D. P., Silman A. J. Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum. 2001 Jun;44(6):1248–1253. doi: 10.1002/1529-0131(200106)44:6<1248::AID-ART215>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  13. Chan K. W., Felson D. T., Yood R. A., Walker A. M. The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum. 1994 Jun;37(6):814–820. doi: 10.1002/art.1780370606. [DOI] [PubMed] [Google Scholar]
  14. Dawes P. T., Fowler P. D., Clarke S., Fisher J., Lawton A., Shadforth M. F. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol. 1986 Feb;25(1):44–49. doi: 10.1093/rheumatology/25.1.44. [DOI] [PubMed] [Google Scholar]
  15. Drossaers-Bakker K. W., de Buck M., van Zeben D., Zwinderman A. H., Breedveld F. C., Hazes J. M. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum. 1999 Sep;42(9):1854–1860. doi: 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  16. Emery P., Breedveld F. C., Dougados M., Kalden J. R., Schiff M. H., Smolen J. S. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis. 2002 Apr;61(4):290–297. doi: 10.1136/ard.61.4.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Emery P., Salmon M. Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis. 1995 Dec;54(12):944–947. doi: 10.1136/ard.54.12.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Feldmann M., Brennan F. M., Maini R. N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. doi: 10.1146/annurev.immunol.14.1.397. [DOI] [PubMed] [Google Scholar]
  19. Felson D. T., Anderson J. J., Boers M., Bombardier C., Chernoff M., Fried B., Furst D., Goldsmith C., Kieszak S., Lightfoot R. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993 Jun;36(6):729–740. doi: 10.1002/art.1780360601. [DOI] [PubMed] [Google Scholar]
  20. Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980 Feb;23(2):137–145. doi: 10.1002/art.1780230202. [DOI] [PubMed] [Google Scholar]
  21. Gravallese E. M., Harada Y., Wang J. T., Gorn A. H., Thornhill T. S., Goldring S. R. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol. 1998 Apr;152(4):943–951. [PMC free article] [PubMed] [Google Scholar]
  22. Green M., Marzo-Ortega H., McGonagle D., Wakefield R., Proudman S., Conaghan P., Gooi J., Emery P. Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis Rheum. 1999 Oct;42(10):2184–2188. doi: 10.1002/1529-0131(199910)42:10<2184::AID-ANR20>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  23. Greenwood M. C., Doyle D. V., Ensor M. Does the Stanford Health Assessment Questionnaire have potential as a monitoring tool for subjects with rheumatoid arthritis? Ann Rheum Dis. 2001 Apr;60(4):344–348. doi: 10.1136/ard.60.4.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Harrison B. J., Symmons D. P., Brennan P., Barrett E. M., Silman A. J. Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol. 1996 Nov;35(11):1096–1100. doi: 10.1093/rheumatology/35.11.1096. [DOI] [PubMed] [Google Scholar]
  25. Harrison B., Symmons D. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Rheumatology (Oxford) 2000 Sep;39(9):939–949. doi: 10.1093/rheumatology/39.9.939. [DOI] [PubMed] [Google Scholar]
  26. Hassell A. B., Davis M. J., Fowler P. D., Clarke S., Fisher J., Shadforth M. F., Jones P. W., Dawes P. T. The relationship between serial measures of disease activity and outcome in rheumatoid arthritis. Q J Med. 1993 Sep;86(9):601–607. [PubMed] [Google Scholar]
  27. Hewlett S., Smith A. P., Kirwan J. R. Values for function in rheumatoid arthritis: patients, professionals, and public. Ann Rheum Dis. 2001 Oct;60(10):928–933. doi: 10.1136/ard.60.10.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Huizinga Tom W. J., Machold Klaus P., Breedveld Ferdinand C., Lipsky Peter E., Smolen Josef S. Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis. Arthritis Rheum. 2002 May;46(5):1155–1159. doi: 10.1002/art.10195. [DOI] [PubMed] [Google Scholar]
  29. Kirwan J. R. Links between radiological change, disability, and pathology in rheumatoid arthritis. J Rheumatol. 2001 Apr;28(4):881–886. [PubMed] [Google Scholar]
  30. Kwoh C. K., O'Connor G. T., Regan-Smith M. G., Olmstead E. M., Brown L. A., Burnett J. B., Hochman R. F., King K., Morgan G. J. Concordance between clinician and patient assessment of physical and mental health status. J Rheumatol. 1992 Jul;19(7):1031–1037. [PubMed] [Google Scholar]
  31. Lard L. R., Visser H., Speyer I., vander Horst-Bruinsma I. E., Zwinderman A. H., Breedveld F. C., Hazes J. M. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med. 2001 Oct 15;111(6):446–451. doi: 10.1016/s0002-9343(01)00872-5. [DOI] [PubMed] [Google Scholar]
  32. Lipsky P. E., van der Heijde D. M., St Clair E. W., Furst D. E., Breedveld F. C., Kalden J. R., Smolen J. S., Weisman M., Emery P., Feldmann M. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000 Nov 30;343(22):1594–1602. doi: 10.1056/NEJM200011303432202. [DOI] [PubMed] [Google Scholar]
  33. Machold K. P., Eberl G., Leeb B. F., Nell V., Windisch B., Smolen J. S. Early arthritis therapy: rationale and current approach. J Rheumatol Suppl. 1998 Jul;53:13–19. [PubMed] [Google Scholar]
  34. Machold Klaus P., Stamm Tanja A., Eberl Gabriele J. M., Nell Valerie K. P., Dunky Attila, Uffmann Martin, Smolen Josef S. Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease. J Rheumatol. 2002 Nov;29(11):2278–2287. [PubMed] [Google Scholar]
  35. Mallya R. K., de Beer F. C., Berry H., Hamilton E. D., Mace B. E., Pepys M. B. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol. 1982 Mar-Apr;9(2):224–228. [PubMed] [Google Scholar]
  36. Molenaar Esmeralda T. H., Voskuyl Alexandre E., Dijkmans Ben A. C. Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission. J Rheumatol. 2002 Feb;29(2):267–270. [PubMed] [Google Scholar]
  37. Mulherin D., Fitzgerald O., Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol. 1996 Dec;35(12):1263–1268. doi: 10.1093/rheumatology/35.12.1263. [DOI] [PubMed] [Google Scholar]
  38. Möttönen T. T. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis. 1988 Aug;47(8):648–653. doi: 10.1136/ard.47.8.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Möttönen T., Hannonen P., Leirisalo-Repo M., Nissilä M., Kautiainen H., Korpela M., Laasonen L., Julkunen H., Luukkainen R., Vuori K. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet. 1999 May 8;353(9164):1568–1573. doi: 10.1016/s0140-6736(98)08513-4. [DOI] [PubMed] [Google Scholar]
  41. Paulus H. E., Egger M. J., Ward J. R., Williams H. J. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. Arthritis Rheum. 1990 Apr;33(4):477–484. doi: 10.1002/art.1780330403. [DOI] [PubMed] [Google Scholar]
  42. Pincus T., Fuchs H. A., Callahan L. F., Nance E. P., Jr, Kaye J. J. Early radiographic joint space narrowing and erosion and later malalignment in rheumatoid arthritis: a longitudinal analysis. J Rheumatol. 1998 Apr;25(4):636–640. [PubMed] [Google Scholar]
  43. Pincus T., Stein C. M., Wolfe F. "No evidence of disease" in rheumatoid arthritis using methotrexate in combination with other drugs: a contemporary goal for rheumatology care? Clin Exp Rheumatol. 1997 Nov-Dec;15(6):591–596. [PubMed] [Google Scholar]
  44. Pincus T. The paradox of effective therapies but poor long-term outcomes in rheumatoid arthritis. Semin Arthritis Rheum. 1992 Jun;21(6 Suppl 3):2–15. doi: 10.1016/0049-0172(92)90008-2. [DOI] [PubMed] [Google Scholar]
  45. Pincus T., Wolfe F. An infrastructure of patient questionnaires at each rheumatology visit: improving efficiency and documenting care. J Rheumatol. 2000 Dec;27(12):2727–2730. [PubMed] [Google Scholar]
  46. Plant M. J., Jones P. W., Saklatvala J., Ollier W. E., Dawes P. T. Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol. 1998 Mar;25(3):417–426. [PubMed] [Google Scholar]
  47. Prevoo M. L., van Gestel A. M., van T Hof M. A., van Rijswijk M. H., van de Putte L. B., van Riel P. L. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol. 1996 Nov;35(11):1101–1105. doi: 10.1093/rheumatology/35.11.1101. [DOI] [PubMed] [Google Scholar]
  48. Proudman S. M., Conaghan P. G., Richardson C., Griffiths B., Green M. J., McGonagle D., Wakefield R. J., Reece R. J., Miles S., Adebajo A. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum. 2000 Aug;43(8):1809–1819. doi: 10.1002/1529-0131(200008)43:8<1809::AID-ANR17>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  49. Redlich Kurt, Hayer Silvia, Maier Andrea, Dunstan Colin R., Tohidast-Akrad Makiyeh, Lang Susanne, Türk Birgit, Pietschmann Peter, Woloszczuk Wolfgang, Haralambous Silva. Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum. 2002 Mar;46(3):785–792. doi: 10.1002/art.10097. [DOI] [PubMed] [Google Scholar]
  50. Sany J., Kaliski S., Couret M., Cuchacovich M., Daures J. P. Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis. J Rheumatol. 1990 Dec;17(12):1636–1641. [PubMed] [Google Scholar]
  51. Scott D. L., Grindulis K. A., Struthers G. R., Coulton B. L., Popert A. J., Bacon P. A. Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis. 1984 Feb;43(1):8–17. doi: 10.1136/ard.43.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Scott D. L., Panayi G. S., van Riel P. L., Smolen J., van de Putte L. B. Disease activity in rheumatoid arthritis: preliminary report of the Consensus Study Group of the European Workshop for Rheumatology Research. Clin Exp Rheumatol. 1992 Sep-Oct;10(5):521–525. [PubMed] [Google Scholar]
  53. Scott D. L. Prognostic factors in early rheumatoid arthritis. Rheumatology (Oxford) 2000 Jun;39 (Suppl 1):24–29. doi: 10.1093/oxfordjournals.rheumatology.a031490. [DOI] [PubMed] [Google Scholar]
  54. Scott D. L., Pugner K., Kaarela K., Doyle D. V., Woolf A., Holmes J., Hieke K. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000 Feb;39(2):122–132. doi: 10.1093/rheumatology/39.2.122. [DOI] [PubMed] [Google Scholar]
  55. Smolen J. S., Breedveld F. C., Schiff M. H., Kalden J. R., Emery P., Eberl G., van Riel P. L., Tugwell P. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003 Feb;42(2):244–257. doi: 10.1093/rheumatology/keg072. [DOI] [PubMed] [Google Scholar]
  56. Smolen J. S., Kalden J. R., Scott D. L., Rozman B., Kvien T. K., Larsen A., Loew-Friedrich I., Oed C., Rosenburg R. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet. 1999 Jan 23;353(9149):259–266. doi: 10.1016/s0140-6736(98)09403-3. [DOI] [PubMed] [Google Scholar]
  57. Smolen J. S., Sokka T., Pincus T., Breedveld F. C. A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S209–S210. [PubMed] [Google Scholar]
  58. Smolen J. S. The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT) Br J Rheumatol. 1992 Apr;31(4):219–220. doi: 10.1093/rheumatology/31.4.219. [DOI] [PubMed] [Google Scholar]
  59. Stenger A. A., Van Leeuwen M. A., Houtman P. M., Bruyn G. A., Speerstra F., Barendsen B. C., Velthuysen E., van Rijswijk M. H. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression. Br J Rheumatol. 1998 Nov;37(11):1157–1163. doi: 10.1093/rheumatology/37.11.1157. [DOI] [PubMed] [Google Scholar]
  60. Stucki G., Liang M. H., Stucki S., Brühlmann P., Michel B. A. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum. 1995 Jun;38(6):795–798. doi: 10.1002/art.1780380612. [DOI] [PubMed] [Google Scholar]
  61. Tunn E. J., Bacon P. A. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol. 1993 Feb;32(2):97–103. doi: 10.1093/rheumatology/32.2.97. [DOI] [PubMed] [Google Scholar]
  62. Visser Henk, le Cessie Saskia, Vos Koen, Breedveld Ferdinand C., Hazes Johanna M. W. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002 Feb;46(2):357–365. doi: 10.1002/art.10117. [DOI] [PubMed] [Google Scholar]
  63. Weinblatt M. E., Kremer J. M., Bankhurst A. D., Bulpitt K. J., Fleischmann R. M., Fox R. I., Jackson C. G., Lange M., Burge D. J. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999 Jan 28;340(4):253–259. doi: 10.1056/NEJM199901283400401. [DOI] [PubMed] [Google Scholar]
  64. Wells G. A., Tugwell P., Kraag G. R., Baker P. R., Groh J., Redelmeier D. A. Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol. 1993 Mar;20(3):557–560. [PubMed] [Google Scholar]
  65. Welsing P. M., van Gestel A. M., Swinkels H. L., Kiemeney L. A., van Riel P. L. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 2001 Sep;44(9):2009–2017. doi: 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  66. Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum. 2000 Dec;43(12):2751–2761. doi: 10.1002/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  67. Wolfe F., Cush J. J., O'Dell J. R., Kavanaugh A., Kremer J. M., Lane N. E., Moreland L. W., Paulus H. E., Pincus T., Russell A. S. Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol. 2001 Jun;28(6):1423–1430. [PubMed] [Google Scholar]
  68. Wolfe F., Sharp J. T. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum. 1998 Sep;41(9):1571–1582. doi: 10.1002/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  69. Woolf A. D., Hall N. D., Goulding N. J., Kantharia B., Maymo J., Evison G., Maddison P. J. Predictors of the long-term outcome of early synovitis: a 5-year follow-up study. Br J Rheumatol. 1991 Aug;30(4):251–254. doi: 10.1093/rheumatology/30.4.251. [DOI] [PubMed] [Google Scholar]
  70. van Gestel A. M., Anderson J. J., van Riel P. L., Boers M., Haagsma C. J., Rich B., Wells G., Lange M. L., Felson D. T. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol. 1999 Mar;26(3):705–711. [PubMed] [Google Scholar]
  71. van Gestel A. M., Prevoo M. L., van 't Hof M. A., van Rijswijk M. H., van de Putte L. B., van Riel P. L. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996 Jan;39(1):34–40. doi: 10.1002/art.1780390105. [DOI] [PubMed] [Google Scholar]
  72. van Leeuwen M. A., van der Heijde D. M., van Rijswijk M. H., Houtman P. M., van Riel P. L., van de Putte L. B., Limburg P. C. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol. 1994 Mar;21(3):425–429. [PubMed] [Google Scholar]
  73. van der Heide A., Jacobs J. W., Bijlsma J. W., Heurkens A. H., van Booma-Frankfort C., van der Veen M. J., Haanen H. C., Hofman D. M., van Albada-Kuipers G. A., ter Borg E. J. The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial. Ann Intern Med. 1996 Apr 15;124(8):699–707. doi: 10.7326/0003-4819-124-8-199604150-00001. [DOI] [PubMed] [Google Scholar]
  74. van der Heijde D. M. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol. 1995 Nov;34 (Suppl 2):74–78. [PubMed] [Google Scholar]
  75. van der Heijde D. M., van 't Hof M., van Riel P. L., van de Putte L. B. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol. 1993 Mar;20(3):579–581. [PubMed] [Google Scholar]
  76. van der Heijde Désirée, Simon Lee, Smolen Josef, Strand Vibeke, Sharp John, Boers Maarten, Breedveld Ferdinand, Weisman Michael, Weinblatt Michael, Rau Rolf. How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion. Arthritis Rheum. 2002 Apr 15;47(2):215–218. doi: 10.1002/art.10181. [DOI] [PubMed] [Google Scholar]
  77. van der Horst-Bruinsma I. E., Speyer I., Visser H., Breedveld F. C., Hazes J. M. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol. 1998 Oct;37(10):1084–1088. doi: 10.1093/rheumatology/37.10.1084. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES